George P. Kim

2.2k total citations
62 papers, 1.6k citations indexed

About

George P. Kim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, George P. Kim has authored 62 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in George P. Kim's work include Pancreatic and Hepatic Oncology Research (26 papers), Colorectal Cancer Treatments and Studies (18 papers) and Cancer Genomics and Diagnostics (12 papers). George P. Kim is often cited by papers focused on Pancreatic and Hepatic Oncology Research (26 papers), Colorectal Cancer Treatments and Studies (18 papers) and Cancer Genomics and Diagnostics (12 papers). George P. Kim collaborates with scholars based in United States, Canada and Australia. George P. Kim's co-authors include Charles Erlichman, Carmen J. Allegra, Soonmyung Paik, Robert R. McWilliams, Ilan R. Kirsch, Linda H. Colangelo, Norman Wolmark, H. Samuel Wieand, Steven R. Alberts and Michelle R. Mahoney and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

George P. Kim

59 papers receiving 1.6k citations

Peers

George P. Kim
Garth D. Nelson United States
Francesco Sclafani United Kingdom
Tadamichi Denda Japan
Veronica Lonati Italy
Salvatore Artale Italy
Kristen K. Ciombor United States
Yihebali Chi China
Benjamin A. Weinberg United States
Kenjiro Kotake Japan
Jenny F. Seligmann United Kingdom
Garth D. Nelson United States
George P. Kim
Citations per year, relative to George P. Kim George P. Kim (= 1×) peers Garth D. Nelson

Countries citing papers authored by George P. Kim

Since Specialization
Citations

This map shows the geographic impact of George P. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George P. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George P. Kim more than expected).

Fields of papers citing papers by George P. Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George P. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George P. Kim. The network helps show where George P. Kim may publish in the future.

Co-authorship network of co-authors of George P. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of George P. Kim. A scholar is included among the top collaborators of George P. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George P. Kim. George P. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, George P., et al.. (2025). Select updates from ASCO and ESMO 2024 for gastrointestinal cancer care. The Oncologist. 30(2). 1 indexed citations
2.
3.
4.
Harton, Joanna, et al.. (2024). First-line treatment patterns among patients with metastatic pancreatic ductal adenocarcinoma in the real-world setting.. Journal of Clinical Oncology. 42(16_suppl). e16320–e16320. 1 indexed citations
5.
Sukrithan, Vineeth, Briant Fruth, Rui Qin, et al.. (2023). A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors. Endocrine Related Cancer. 30(11). 4 indexed citations
6.
MacEwan, Joanna P., et al.. (2023). Dosing patterns and treatment patterns in real-world patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) who received FOLFIRINOX in the first line.. Journal of Clinical Oncology. 41(16_suppl). e16255–e16255. 1 indexed citations
7.
Yoon, Harry H., Fang‐Shu Ou, Gamini S. Soori, et al.. (2021). Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance]). European Journal of Cancer. 150. 214–223. 13 indexed citations
8.
9.
Pedersen, Katrina S., George P. Kim, Nathan R. Foster, et al.. (2015). Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study. Investigational New Drugs. 33(4). 963–968. 47 indexed citations
10.
Deng, Yanhong, Li Wang, George P. Kim, et al.. (2015). KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancer. Molecular Oncology. 9(7). 1341–1347. 40 indexed citations
11.
Loon, Katherine Van, David R. Fogelman, Robert A. Wolff, et al.. (2014). Should Combination Chemotherapy Serve as the Backbone in Clinical Trials of Advanced Pancreatic Cancer?. Pancreas. 43(3). 343–349. 8 indexed citations
12.
Peterson, Jennifer, Laura A. Vallow, Douglas Johnson, et al.. (2013). Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: An evaluation of 112 patients. Brachytherapy. 12(6). 573–579. 28 indexed citations
13.
Nguyen, Justin H., Barry Rosser, Raouf E. Nakhleh, et al.. (2011). Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma. Liver Transplantation. 18(5). 594–601. 22 indexed citations
14.
Alberts, Steven R., Joel M. Reid, Bruce W. Morlan, et al.. (2011). Gemcitabine and Docetaxel for Hepatocellular Carcinoma. American Journal of Clinical Oncology. 35(5). 418–423. 14 indexed citations
15.
Alberts, Steven R., Tom R. Fitch, George P. Kim, et al.. (2011). Cediranib (AZD2171) in Patients With Advanced Hepatocellular Carcinoma. American Journal of Clinical Oncology. 35(4). 329–333. 54 indexed citations
16.
Harnois, Denise M., Raj Satyanarayana, Murli Krishna, et al.. (2010). Retransplantation for donor-derived neuroendocrine tumor. Liver Transplantation. 17(1). 83–87. 6 indexed citations
17.
McWilliams, Robert R., Martha Matsumoto, Patrick A. Burch, et al.. (2010). Obesity adversely affects survival in pancreatic cancer patients. Cancer. 116(21). 5054–5062. 75 indexed citations
18.
Kim, George P., Michelle R. Mahoney, Daniel Szydlo, et al.. (2010). An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma. Investigational New Drugs. 30(1). 387–394. 62 indexed citations
19.
Alberts, Steven R., Gregory J. Gores, George P. Kim, et al.. (2007). Treatment Options for Hepatobiliary and Pancreatic Cancer. Mayo Clinic Proceedings. 82(5). 628–637. 44 indexed citations
20.
Loprinzi, Charles L., Ralph Levitt, Debra L. Barton, et al.. (2005). Evaluation of shark cartilage in patients with advanced cancer. Cancer. 104(1). 176–182. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Garth D. Nelson Breakdown of academic impact, for papers by Francesco Sclafani Breakdown of academic impact, for papers by Tadamichi Denda Breakdown of academic impact, for papers by Veronica Lonati Breakdown of academic impact, for papers by Salvatore Artale Breakdown of academic impact, for papers by Kristen K. Ciombor Breakdown of academic impact, for papers by Yihebali Chi Breakdown of academic impact, for papers by Benjamin A. Weinberg Breakdown of academic impact, for papers by Kenjiro Kotake Breakdown of academic impact, for papers by Jenny F. Seligmann
Rankless by CCL
2026